Interscalene Block Alone Versus Interscalene Block With Erector Spinae Plane Block for Shoulder Arthroscopy Anesthesia

NCT ID: NCT05646667

Last Updated: 2024-03-26

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-12-15
• Study Completion Date: 2024-02-15

Brief Summary

The aim of this study is to compare the effectiveness of interscalene brachial plexus block alone versus interscalene brachial plexus block +Erector spinae plane block in anesthesia for shoulder arthroscopy.

Detailed Description

Regional anesthetic techniques can control pain effectively, both at rest and on movement, allowing earlier mobilization without the adverse effects of opioids . Among the various types of regional anesthetic techniques, the interscalene brachial plexus block is a gold standard used nerve block technique for postoperative analgesia in patients undergoing shoulder surgery, as it has consistently been shown to significantly control.

Conditions

Interscalene Block; Erector Spinae Plane Block; Shoulder Arthroscopy Anesthesia; Randomized Controlled Trial

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

Interscalene with erector spinae plane block group

Patients will receive interscalene brachial plexus block using 10 ml of bupivacaine 0.5% and ultrasound guided erector spinae plane block at thoracic (T2) using 10 ml of bupivacaine 0.5%.

Group Type: EXPERIMENTAL

interscalene with Erector spinae plane block group

Intervention Type: OTHER

patients will receive interscalene brachial plexus block using 10 ml of bupivacaine 0.5% and US guided Erector spinae plane block at T2 using 10 ml of bupivacaine 0.5%.

Interscalene group

Patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5%.

Group Type: EXPERIMENTAL

Interscalene group

Intervention Type: OTHER

patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5%.

Interventions

interscalene with Erector spinae plane block group

patients will receive interscalene brachial plexus block using 10 ml of bupivacaine 0.5% and US guided Erector spinae plane block at T2 using 10 ml of bupivacaine 0.5%.

Intervention Type: OTHER

Interscalene group

patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5%.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Aged 18-65 years
• Both genders,
• BMI < 40 kg/m2
• American Society of Anesthesiologists (ASA) physical status I-II
• Scheduled for elective shoulder arthroscopy.

Exclusion Criteria

• Known allergy to local anesthetics,
• allergy to all opioid medications, diagnostic shoulder arthroscopic procedures,
• patients with chronic opioids,
• patients who converted to general anesthesia use and coagulopathy

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Tanta University

OTHER

Sponsor Role: lead

Responsible Party

Islam Morsy

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Islam Morsy, MD

Role: PRINCIPAL_INVESTIGATOR

Tanta University

Locations

Islam Morsy

Tanta, , Egypt

Countries

Egypt

Other Identifiers

35915/10/22

Identifier Type: -

Identifier Source: org_study_id